The Valley Desk

NCT02098343 · Interventional trial

p53 Suppressor Activation in Recurrent High Grade Serous Ovarian Cancer, a Phase Ib/II Study of Systemic Carboplatin Combination Chemotherapy With or Without APR-246

Overall registry status Completed

Phase 1 · Phase 2

Conditions Platinum Sensitive Recurrent High-grade Serous Ovarian Cancer With Mutated p53

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov